Related Experiment Videos
Increased resistance of diabetic rats to acetaminophen-induced hepatotoxicity
Abstract:
The effects of insulin-deficient diabetes on acetaminophen-induced hepatotoxicity and metabolism were investigated in streptozotocin-treated male rats. Diabetic rats were less susceptible to acetaminophen-induced liver injury than normal rats. The protective effect was reversed by the administration of insulin. Diabetic rats metabolized acetaminophen at a faster rate than normal rats, as evidenced by a shorter blood half-life. Pharmacokinetic studies revealed that the increased metabolic clearance was largely the result of a markedly enhanced glucuronidation capacity. The rate of formation of acetaminophen sulfate was also modestly increased in diabetic animals, whereas the apparent rate of the toxic pathway was approximately equal in both normal and diabetic animals. Steady-state levels of hepatic glutathione were significantly higher in diabetic rats. After a large dose of acetaminophen, the rate and relative amount of hepatic glutathione depletion were similar in both groups; however, the absolute amount of glutathione was always greater in diabetic animals. These data indicate that insulin-deficient diabetic male rat are more resistant to acetaminophen-induced hepatotoxicity as a result of an increased capacity to eliminate the drug as the nontoxic glucuronide and sulfate conjugates and an increased glutathione-dependent detoxification capacity.
Insights
Insulin-deficient diabetes protects male rats from acetaminophen liver injury by increasing drug metabolism and glutathione levels. Insulin therapy reversed this protective effect, highlighting diabetes-related metabolic changes.
Area of Science:
- Toxicology
- Pharmacology
- Endocrinology
Background:
- Acetaminophen overdose is a leading cause of acute liver failure.
- Diabetes mellitus is associated with altered drug metabolism and potential changes in drug toxicity.
- The specific impact of insulin-deficient diabetes on acetaminophen hepatotoxicity requires further elucidation.
Purpose of the Study:
- To investigate the effects of insulin-deficient diabetes on acetaminophen-induced hepatotoxicity in male rats.
- To examine the influence of diabetes on acetaminophen metabolism and detoxification pathways.
- To determine the role of insulin in modulating acetaminophen toxicity in diabetic models.
Main Methods:
- Male rats were rendered diabetic using streptozotocin.
- Diabetic and normal rats were challenged with acetaminophen to assess liver injury.
- Pharmacokinetic studies were performed to analyze acetaminophen metabolism, including glucuronidation, sulfation, and glutathione conjugation.
- Hepatic glutathione levels were measured in both groups.
Main Results:
- Diabetic rats exhibited significantly reduced susceptibility to acetaminophen-induced hepatotoxicity compared to normal rats.
- Insulin administration reversed the protective effect observed in diabetic rats.
- Acetaminophen metabolism was accelerated in diabetic rats, characterized by enhanced glucuronidation and modestly increased sulfation.
- Steady-state hepatic glutathione levels were higher in diabetic rats, with greater absolute amounts despite similar depletion rates post-acetaminophen challenge.
Conclusions:
- Insulin-deficient diabetes confers resistance to acetaminophen hepatotoxicity in male rats.
- This protection is attributed to enhanced drug elimination via glucuronide and sulfate conjugation and increased glutathione-dependent detoxification.
- Metabolic alterations in diabetes play a crucial role in modifying acetaminophen toxicity.